Barbara D. Buch, M.D., Chair of the 907 Steering committee and the Associate Director for Medicine in FDA’s Center for Biologics Evaluation and Research, recently posted on FDA Voice her reflections on a focused action plan to support inclusion of diverse populations...
The Indiana University’s Kelley Living Learning Center (KLLC) will be hosting their second annual Women’s Empowerment Retreat on March 4th. We are proud to announce that our own Pearl Pathways’ President and CEO, Diana Caldwell will be speaking at this event and...
Melissa Fassbender of Outsourcing-Pharma.com recently published an article about The International Committee of Medical Journal Editors (ICMJE) proposing authors share clinical trial data as a prerequisite to publish. The ICMJE brings up a very good point that...
View the outstanding panel discussion on clinical research at the IHIF and Barnes & Thornburg luncheon event featuring Pearl Pathways’ CEO and President, Diana Caldwell here. For information on future IHIF programs with updates from Life Science industry...
Insight Pharma Reports interviewed 100 clinical trials professionals asking questions on issues of patient enrollment, how mobile technology is working, patient engagement and clinical trial software. According to the survey results, clinical trials staff have...